Search Results - "LATHAN, Christopher"

Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer by Lathan, Christopher S, Cronin, Angel, Tucker-Seeley, Reginald, Zafar, S Yousuf, Ayanian, John Z, Schrag, Deborah

“…To measure the association between patient financial strain and symptom burden and quality of life (QOL) for patients with new diagnoses of lung or colorectal…”
Get full text

Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline by Gilligan, Timothy, Coyle, Nessa, Frankel, Richard M, Berry, Donna L, Bohlke, Kari, Epstein, Ronald M, Finlay, Esme, Jackson, Vicki A, Lathan, Christopher S, Loprinzi, Charles L, Nguyen, Lynne H, Seigel, Carole, Baile, Walter F

“…Purpose To provide guidance to oncology clinicians on how to use effective communication to optimize the patient-clinician relationship, patient and clinician…”
Get full text

Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival by Soneji, Samir, Tanner, Nichole T., Silvestri, Gerard A., Lathan, Christopher S., Black, William

“…Black patients with lung cancer diagnosed at early stages—for which surgical resection offers a potential cure—experience worse overall survival than do their…”
Get full text

Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer by Kehl, Kenneth L, Lathan, Christopher S, Johnson, Bruce E, Schrag, Deborah

“…Data are limited regarding whether the availability of biomarker-directed therapy for lung cancer exacerbates racial and socioeconomic disparities. Patients…”
Get full text

Race and sex differences in patient provider communication and awareness of lung cancer screening in the health information National Trends Survey, 2013–2017 by Warner, Erica T., Lathan, Christopher S.

“…Despite demonstrated reduction in lung cancer mortality, lung cancer screening uptake has been low. We investigated differences in discussions with physicians…”
Get full text

Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck by Chau, Nicole G., Hurwitz, Shelley, Mitchell, Chelsey M., Aserlind, Alexandra, Grunfeld, Noam, Kaplan, Leah, Hsi, Peter, Bauer, Daniel E., Lathan, Christopher S., Rodriguez‐Galindo, Carlos, Tishler, Roy B., Haddad, Robert I., Sallan, Stephen E., Bradner, James E., French, Christopher A.

“…BACKGROUND NUT midline carcinoma is a rare and aggressive genetically characterized subtype of squamous cell carcinoma frequently arising from the head and…”
Get full text

Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer by Yasuda, Hiroyuki, Park, Eunyoung, Yun, Cai-Hong, Sng, Natasha J, Lucena-Araujo, Antonio R, Yeo, Wee-Lee, Huberman, Mark S, Cohen, David W, Nakayama, Sohei, Ishioka, Kota, Yamaguchi, Norihiro, Hanna, Megan, Oxnard, Geoffrey R, Lathan, Christopher S, Moran, Teresa, Sequist, Lecia V, Chaft, Jamie E, Riely, Gregory J, Arcila, Maria E, Soo, Ross A, Meyerson, Matthew, Eck, Michael J, Kobayashi, Susumu S, Costa, Daniel B

“…Epidermal growth factor receptor (EGFR) gene mutations (G719X, exon 19 deletions/insertions, L858R, and L861Q) predict favorable responses to EGFR tyrosine…”
Get more information

Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma by BAUER, Daniel E, MITCHELL, Chelsey M, GIRALDI, Eugenia, OAKLEY, Richard P, RODRIGUEZ-GALINDO, Carlos, LONDON, Wendy B, SALLAN, Stephen E, BRADNER, James E, FRENCH, Christopher A, STRAIT, Kelly M, LATHAN, Christopher S, STELOW, Edward B, LÜER, Sonja C, MUHAMMED, Somala, EVANS, Andrew G, SHOLL, Lynette M, ROSAI, Juan

“…NUT midline carcinoma (NMC) is a poorly differentiated squamous cancer characterized by rearrangement of the NUT gene. Research advances have provided…”
Get full text

Religiousness and Spiritual Support Among Advanced Cancer Patients and Associations With End-of-Life Treatment Preferences and Quality of Life by BALBONI, Tracy A, VANDERWERKER, Lauren C, BLOCK, Susan D, PAULK, M. Elizabeth, LATHAN, Christopher S, PETEET, John R, PRIGERSON, Holly G

“…Religion and spirituality play a role in coping with illness for many cancer patients. This study examined religiousness and spiritual support in advanced…”
Get full text

Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia by Hantel, Andrew, Luskin, Marlise R, Khan, Irum, Warner, Elizabeth, Patel, Anand A, Walsh, Thomas P, DeAngelo, Daniel J, Lathan, Christopher S, Abel, Gregory A

“…Clinical trial eligibility criteria can unfairly exclude patients or unnecessarily expose them to known risks if criteria are not concordant with drug safety…”
Get full text

Disparities in perceived unmet need for supportive services among patients with lung cancer in the Cancer Care Outcomes Research and Surveillance Consortium by John, Dolly A., Kawachi, Ichiro, Lathan, Christopher S., Ayanian, John Z.

“…BACKGROUND The authors investigated the prevalence, determinants of, and disparities in any perceived unmet need for 8 supportive services (home nurse, support…”
Get full text

Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey by Pohl, Sarah A., Nelson, Barry A., Patwary, Tanjeena R., Amanuel, Salina, Benz, Edward J., Lathan, Christopher S.

“…Cancer mortality rates have declined during the last 28 years, but that process is not equitably shared. Disparities in cancer outcomes by race, ethnicity,…”
Get full text

A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors by SASAKI, Takaaki, KOIVUNEN, Jussi, CAPELLETTI, Marzia, SHIMAMURA, Takeshi, ERCAN, Dalia, STUMPFOVA, Magda, YUN XIAO, WEREMOWICZ, Stanislawa, BUTANEY, Mohit, HEON, Stephanie, WILNER, Keith, CHRISTENSEN, James G, OGINO, Atsuko, ECK, Michel J, WONG, Kwok-Kin, LINDEMAN, Neal, GRAY, Nathanael S, RODIG, Scott J, JÄNNE, Pasi A, YANAGITA, Masahiko, NIKIFOROW, Sarah, ZHENG, Wei, LATHAN, Christopher, PAUL MARCOUX, J, JINYAN DU, OKUDA, Katsuhiro

“…Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKI), including crizotinib, are effective treatments in preclinical models and in cancer patients…”
Get full text

An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients by Chau, Nicole G, Ma, Clement, Danga, Kristina, Al-Sayegh, Hasan, Nardi, Valentina, Barrette, Ryan, Lathan, Christopher S, DuBois, Steven G, Haddad, Robert I, Shapiro, Geoffrey I, Sallan, Stephen E, Dhar, Arindam, Nelson, Jeanenne J, French, Christopher A

“…NUT midline carcinoma, renamed NUT carcinoma (NC), is an aggressive squamous cancer defined by rearrangement of the gene. Although a subset of patients can be…”
Get full text

Racial disparities in treatment delay among younger men with prostate cancer by Jain, Bhav, Yamoah, Kosj, Lathan, Christopher S., Muralidhar, Vinayak, Mahal, Brandon A., Nguyen, Paul L., Dee, Edward Christopher

“…Young men (≤55 years) with prostate cancer (PC) may experience treatment delays despite clinical consequences of delays beyond six months. Using the United…”
Get full text

Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for Intervention by Hantel, Andrew, Kohlschmidt, Jessica, Eisfeld, Ann-Kathrin, Stock, Wendy, Jacobson, Sawyer, Mandrekar, Sumithra, Larson, Richard A, Stone, Richard M, Lathan, Christopher S, DeAngelo, Daniel J, Byrd, John C, Abel, Gregory A

“…Representativeness in acute leukemia clinical research is essential for achieving health equity. The National Cancer Institute's mandate for Comprehensive…”
Get full text

Racial and ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemia by Hantel, Andrew, Brunner, Andrew M, Plascak, Jesse J, Uno, Hajime, Varela, Juan C, Luskin, Marlise R, Rebbeck, Timothy R, Stone, Richard M, Lathan, Christopher S, DeAngelo, Daniel J, Abel, Gregory A

“…Clinical trial participation at Comprehensive Cancer Centers (CCC) is inequitable for minoritized racial and ethnic groups with acute leukemia. CCCs care for a…”
Get full text

Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute by Polite, Blase N, Adams-Campbell, Lucile L, Brawley, Otis W, Bickell, Nina, Carethers, John M, Flowers, Christopher R, Foti, Margaret, Gomez, Scarlett Lin, Griggs, Jennifer J, Lathan, Christopher S, Li, Christopher I, Lichtenfeld, J Leonard, McCaskill-Stevens, Worta, Paskett, Electra D

Get full text

Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations by Sholl, Lynette M, Nishino, Mizuki, Pokharel, Saraswati, Mino-Kenudson, Mari, French, Christopher A, Janne, Pasi A, Lathan, Christopher

“…NUT midline carcinoma (NMC) is a poorly differentiated tumor typically driven by a t(15;19) rearrangement leading to a NUT fusion event. This rare and…”
Get more information

Pathologic characteristics of NUT midline carcinoma arising in the mediastinum by Evans, Andrew G, French, Christopher A, Cameron, Michael J, Fletcher, Christopher D M, Jackman, David M, Lathan, Christopher S, Sholl, Lynette M

“…NUT midline carcinomas (NMCs) comprise a group of highly aggressive tumors that have been reported primarily in the head, neck, and mediastinum of younger…”
Get full text